ADDvise Group

On 28 May 2025, ADDvise Group AB (publ) (“ADDvise”) successfully issued senior unsecured bonds in an amount of SEK 800 million, under a total framework of SEK 1,600 million (the “Bonds”).

Pursuant to the terms and conditions for the Bonds, ADDvise has undertaken to apply for admission to trading of the Bonds on the corporate bond list of Nasdaq Stockholm. For this purpose, the company has prepared a listing prospectus, which today has been approved by the Swedish Financial Supervisory Authority (Sw. Finansinspektionen). The prospectus is available at the company’s website www.addvisegroup.com and at the Swedish Financial Supervisory Authority’s website www.fi.se. The application for admission to trading has been submitted and the first day of trading of the Bonds is estimated to be around 15 July 2025.

For further information, please contact:

Staffan Torstensson, CEO

+46 70 433 20 19

staffan.torstensson@addvisegroup.se

Johan Irwe, CFO

+46 73 731 26 11

johan.irwe@addvisegroup.se

About ADDvise Group

ADDvise is an international life science group. Operating a decentralised ownership model, we develop and acquire high quality companies within the business areas Lab and Healthcare. The Group comprises more than 20 companies and generates annual revenues of close to SEK 1.7 billion. ADDvise is listed on Nasdaq First North Premier Growth Market. Mangold Fondkommission AB, +46 8 503 015 50, CA@mangold.se, is the company's Certified Adviser. More information is available at www.addvisegroup.com.